Ozempic.Photo:Getty
Getty
Pharmaceutical companies have raised prices for hundreds of medications in 2024, new research shows.
46Brooklyn Research, a nonprofit drug-pricing analytics group, recently releaseddatathat showed some drugmakers had raised the prices of their medications already this year, including popular drugs Ozempic and Mounjara, with some increases at 9% or higher.
Companies including Novo Nordisk — which produces Ozempic, a drug designed to help diabetics regulate their blood sugar that has also been found to be effective for weight loss — and Eli Lilly, which sells the similar drug Mounjaro, were on the list.
Never miss a story — sign up forPEOPLE’s free daily newsletterto stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories.
Pill bottles.Getty
Other drugs that had seen price increases include the autoimmune disease medication Enbrel, the pain medication Oxycontin, the blood thinner Plavix and the antidepressant Wellbutrin.
46Brooklyn’s data does not fully reflect what a consumer pays for a drug, however, as its analysis is based on the price that drugmakers charge to those who distribute the drugs to pharmacies, the company said.
Consumers can sometimes pay less due to factors such as insurance coverage or other discounts like rebates.
Pills.Getty Images/arnphoto
Getty Images/arnphoto
46Brooklyn also highlighted around two dozen medications that dropped in price at the start of the new year.
source: people.com
